Earnings History Data for RxSight, Inc. (RXST) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
RxSight, Inc.
RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | AH | RXST | RxSight, Inc. | 2,050 | -0.16 | -0.19 | -0.35 | RxSight Non-GAAP EPS of $0.00 beats by $0.07, revenue of $35.3M beats by $0.23M [11/7/2024 4:33 PM] |
47.89 | -2.96 (-5.82%) |
47.27 | -3.58 (-7.03%) |
22.91 - 66.54 | 2,691,761 | 530,000 | 1,121 | ||
| 05-08-2024 | AH | RXST | RxSight, Inc. | 1,650 | -0.16 | -0.21 | -0.40 | RxSight Non-GAAP EPS of $0.00 beats by $0.11, revenue of $34.9M beats by $2.57M [8/5/2024 4:13 PM] |
47.86 | 7.08 (17.36%) |
49.68 | 8.90 (21.82%) |
20.66 - 66.54 | 1,345,017 | 750,000 | 30,792 | ||
| 06-05-2024 | AH | RXST | RxSight, Inc. | 2,210 | -0.25 | -0.26 | -0.42 | RxSight Non-GAAP EPS of -$0.12 beats by $0.07, revenue of $29.5M beats by $1.94M [5/6/2024 4:15 PM] |
62.12 | -0.73 (-1.15%) |
67.06 | 4.22 (6.72%) |
18.35 - 66.54 | 531,817 | 440,000 | 949 | ||
| 28-02-2024 | AH | RXST | RxSight | 1,963 | -0.26 | -0.36 | 0.00 | RxSight Non-GAAP EPS of -$0.13 beats by $0.14, revenue of $28.6M beats by $0.74M [2/28/2024 4:58 PM] |
54.59 | -1.80 (-3.19%) |
58.50 | 2.11 (3.74%) |
13.00 - 58.04 | 692,700 | 490,000 | 1,938 | ||
| 09-11-2023 | AH | RXST | RxSight, Inc. | 892.52 | -0.35 | -0.42 | -0.61 | RxSight Non-GAAP EPS of -$0.19 beats by $0.16, revenue of $22.2M beats by $1.65M [11/9/2023 4:41 PM] |
25.29 | 1.49 (6.26%) |
24.11 | 0.31 (1.30%) |
10.29 - 33.77 | 797,186 | 650,000 | 1,267 | ||
| 07-08-2023 | AH | RXST | RxSight, Inc. | 1,080 | -0.40 | -0.47 | -0.61 | RxSight Non-GAAP EPS of -$0.28 beats by $0.11, revenue of $20.8M beats by $1.57M [8/7/2023 4:58 PM] |
29.58 | 0.74 (2.57%) |
31.36 | 2.52 (8.74%) |
9.78 - 33.77 | 825,479 | 540,000 | 4,920 | ||
| 09-05-2023 | AH | 4:05 PM ET (May 9) |
RXST | RxSight, Inc. | 623.40 | -0.42 | -0.52 | -0.64 | RxSight Non-GAAP EPS of -$0.31 beats by $0.14, revenue of $17.5M beats by $1.22M [5/9/2023 4:51 PM] |
21.12 | 1.87 (9.71%) |
21.00 | 1.75 (9.09%) |
9.78 - 23.79 | 1,025,749 | 380,000 | 7,079 | |
| 06-03-2023 | AH | 4:05 PM ET (Mar 6) |
RXST | RxSight, Inc. | 452.49 | -0.56 | -0.68 | -0.58 | RxSight Non-GAAP EPS of -$0.45 beats by $0.29, revenue of $16.1M in-line, guidance above consensus [3/6/2023 4:12 PM] |
15.27 | -0.42 (-2.68%) |
16.00 | 0.31 (1.98%) |
9.78 - 16.99 | 398,161 | 120,000 | 2,250 | |
| 07-11-2022 | AH | 4:05 PM ET (Nov 7) |
RXST | RxSight, Inc. | 318.40 | -0.61 | -0.70 | -0.76 | RxSight GAAP EPS of -$0.61 beats by $0.10, revenue of $12.6M beats by $1.62M [11/7/2022 4:33 PM] |
13.38 | 0.76 (5.98%) |
15.00 | 2.38 (18.86%) |
8.80 - 16.99 | 84,851 | 50,000 | 1,442 | |
| 08-08-2022 | AH | 4:05 PM ET (Aug 8) |
RXST | RxSight, Inc. | 401.58 | -0.61 | -0.68 | -3.58 | RxSight Non-GAAP EPS of -$0.50 beats by $0.15, revenue of $11.4M beats by $0.85M [8/8/2022 4:26 PM] |
15.16 | -0.48 (-3.10%) |
16.89 | 1.24 (7.92%) |
8.80 - 16.99 | 135,098 | 50,000 | 330 | |
| 05-05-2022 | AH | 4:05 PM ET (May 5) |
RXST | RxSight, Inc. | 331.20 | -0.64 | -0.66 | 0.00 | RxSight Non-GAAP EPS of -$0.54 beats by $0.06, revenue of $8.9M beats by $1.57M [5/5/2022 5:02 PM] |
11.35 | 0.74 (6.97%) |
10.60 | -0.01 (-0.09%) |
8.80 - 19.67 | 232,384 | 60,000 | 300 | |
|
||||||||||||||||||
| 08-03-2022 | AH | 4:05 PM ET (Mar 8) |
RXST | RxSight, Inc. | 362.17 | -0.58 | -0.60 | 0.00 | RxSight reports Q4 results [3/8/2022 4:42 PM] |
13.53 | 1.42 (11.73%) |
12.95 | 0.84 (6.94%) |
8.80 - 19.67 | 132,459 | 150,000 | 110 | |
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
RXST | RxSight, Inc. | 361.35 | -0.76 | -0.61 | 0.00 | RxSight EPS beats by $0.01, beats on revenue [11/10/2021 4:51 PM] |
12.63 | 0.53 (4.38%) |
12.00 | -0.10 (-0.83%) |
11.19 - 19.67 | 80,388 | 80,000 | 390 | |
| 09-09-2021 | AH | After the close (Sep 9) |
RXST | RxSight, Inc. | 434.33 | -3.58 | -0.68 | 0.00 | RxSight reports Q2 results [9/9/2021 4:36 PM] |
13.30 | -2.69 (-16.82%) |
16.50 | 0.51 (3.19%) |
11.19 - 19.67 | 207,029 | 140,000 | 1,496 | |